PPARα agonists (fenofibrate, Wyeth14,643, clofibrate) can induce cancer cell apoptosis and inhibit tumor angiogenesis in a PPARα dependent or independent manner [19, 21, 25–27], while our results show that these ligands had no significant effect on Bcl2 protein levels. Here, BCL2 is linked to neoplasm.